Table 1.
Peptide No. | Sequencea | CPP | IC50 (nM) | |
---|---|---|---|---|
TCPTP | PTP1B | |||
1 | Pro-Tyr-Ala-F2Pmp-Pip | I | ND | ND |
2 | Pro-Ile-Asp-F2Pmp-Pip | J | ND | ND |
3 | Asp-Asp-thr-F2Pmp-Pip | J | ND | ND |
4 | Asp-glu-Asp-F2Pmp-Ile | J | 550 ± 140 | 1200 ± 700 |
5 | Gln-Asp-Abu-F2Pmp-Ala | C | 660 ± 280 | 1750 ± 260 |
6 | Gln-Asp-Phe-F2Pmp-Ala | J | 470 ± 70 | 1190 ± 30 |
7 | Gln-Asp-Ile-F2Pmp-Ala | J | 340 ± 50 | 1150 ± 490 |
8 | Gln-Asp-Val-F2Pmp-Ala | J | 380 ± 110 | 580 ± 70 |
9 | Gln-Asp-Ala-F2Pmp-Ala | J | 1110 ± 70 | 1430 ± 40 |
10 | Gln-Asp-Ser-F2Pmp-Ala | J | 530 ± 40 | 840 ± 10 |
11 | Gln-Asp-Nva-F2Pmp-Ala | J | 610 ± 280 | 1320 ± 250 |
12 | Gln-Asp-Nle-F2Pmp-Ala | J | 580 ± 100 | 1100 ± 60 |
13 | Gln-Asp-Ile-F2Pmp-Abu | I | 400 | 1600 |
14 | Gln-Asp-Ile-F2Pmp-Ile | J | 240 | 500 |
15 | Gln-Asp-Ile-F2Pmp-Val | J | 420 | 730 |
16 | Gln-Asp-Ile-F2Pmp-thr | J | >2000 | >2000 |
17 | Gln-Asp-Ile-F2Pmp-Gln | J | 210 ± 50 | 590 ± 260 |
18 | Gln-Asp-Ile-F2Pmp-Asn | J | 380 ± 5 | 910 ± 410 |
19 | Gln-Asp-Ile-F2Pmp-Nle | J | 290 ± 120 | 840 ± 150 |
20 | Gln-Asp-Ile-F2Pmp-Leu | J | 140 ± 40 | 260 ± 60 |
21 | Gln-Asp-Ile-F2Pmp-Tle | J | 680 ± 140 | 560 ± 90 |
22 | Gln-glu-Ile-F2Pmp-Leu | J | 1120 | 1270 |
23 | Gln-asp-Ile-F2Pmp-Leu | J | 1090 | 1340 |
24 | Gln-phe-Ile-F2Pmp-Leu | J | 250 | 530 |
25 | Gln-Fpa-Ile-F2Pmp-Leu | J | 110 ± 16 | 420 ± 200 |
26 | Gln-Glu-Ile-F2Pmp-Leu | J | 250 | 410 |
27 | Gln-Tyr-Ile-F2Pmp-Leu | J | 140 | 210 |
28 | Ala-Fpa-Ile-F2Pmp-Leu | J | 140 ± 10 | 280 ± 2 |
29 | Pro-Fpa-Ile-F2Pmp-Leu | J | 140 ± 20 | 290 ± 70 |
30 | glu-Fpa-Ile-F2Pmp-Leu | J | 47 ± 3 | 46 ± 17 |
31 | Phg-Fpa-Ile-F2Pmp-Leu | J | 310 ± 230 | 350 ± 240 |
32 | ser-Fpa-Ile-F2Pmp-Leu | J | 140 ± 40 | 100 ± 20 |
33 | Gln-Fpa-Ile-Tyr-Leu | J | ND | ND |
Only the randomized region is shown. Three-letter codes in all lowercase letters indicate D-amino acids. ND, not determined due to no significant inhibition.